DAIC
JUNE 12, 2024
and an investigator in the VIVID study , which contributed to the device’s FDA approval – successfully used the Duo Venous Stent System for the first time outside of a clinical trial. Duo Hybrid has a distinct integrated design that combines multiple zones of differing mechanical properties into a single stent [3].
DAIC
MARCH 1, 2024
Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. vs. 28.7%; P=0.006).
Circulation
JANUARY 27, 2025
BACKGROUND:In patients with post-thrombotic syndrome, stent recanalization of iliofemoral veins or the inferior vena cava can restore venous patency and improve functional outcomes. The risk of stent thrombosis is particularly increased during the first 6 months after intervention. points (P=0.36), respectively.
ADN Center of Excellence
NOVEMBER 7, 2024
Our Interventional Cardiology Fellowship Program offers a unique opportunity for fellows to immerse themselves in high-volume centers and experience complex procedures such as angioplasties, stent placements, and Chronic Total Occlusion (CTO) interventions.
DAIC
FEBRUARY 14, 2024
Diseased human arteries are most simply, reliably, and successfully treated with drug-eluting, balloon-expandable stents," said Lewis B. Symptomatic PAOD causes poor physical health, loss of mobility and independence, decreased quality of life, premature functional decline and early mortality.2
American College of Cardiology
FEBRUARY 1, 2025
Clinicians working with older patients have witnessed firsthand how polypharmacy can complicate both their care and diminish quality of life. had one or more severe potential drug-drug interaction.1 1 There has been a dramatic increase in the risk of drug-drug interactions and ADRs.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Initially, he underwent stent‐assisted coiling of a high‐riding jugular bulb with no change in symptoms. She underwent stent‐assisted coil embolization of the PCV and stenting of her IJ with resolution of her tinnitus.Case 4A 56‐year‐old female was seen for left‐sided PT, ear fullness, and reduced hearing.
Expert insights. Personalized for you.
105 
Let's personalize your content